DipStik-Seq is a portable, shelf-stable nucleic acid isolation and detection platform adapted for plant DNA testing. Originally developed for at-home STD screening, it uses a silica dipstick for lab-free DNA capture paired with a non-enzymatic colorimetric assay, enabling rapid field-deployable genetic identification for agriculture and biosecurity applications.
DipStik-Seq is a point-of-care nucleic acid detection technology developed by ama biotech Inc, now being adapted for plant DNA testing. The platform combines a simple, shelf-stable silica dipstick isolation method with a non-enzymatic colorimetric DNA strand displacement assay, eliminating the need for laboratory infrastructure. Originally created for at-home STD testing using menstrual samples, the technology is well-suited for any application where cell-free DNA is abundant, including agricultural pathogen detection, crop verification, and plant biosecurity screening. The plant adaptation requires only a single lysis step to liberate DNA from plant tissue before dipstick capture and colorimetric detection.
Key features:
How it works: A plant tissue sample is disrupted in a single tube using a lysis solution, releasing DNA into the crude lysate. The DipStik binds nucleic acids selectively from this mixture, which are then eluted and tested for unique genetic sequences via a colorimetric strand displacement cascade. Alternative detection methods, including field-deployable PCR, are being explored for non-consumer-facing applications.
The core DipStik isolation and colorimetric detection technology has been validated with human cell-free DNA samples, demonstrating successful capture and detection of a ~15-nucleotide target sequence by both DNA strand displacement assay and PCR. Purity assessments by spectrophotometry confirmed a discrete absorbance peak at 260 nm, though some residual signal around 400–430 nm suggests minor contaminants. An initial proof-of-concept with moth DNA in a teaching lab demonstrated that a single lysis step enables plant-tissue DNA capture. The plant-specific adaptation is in early-stage development, with a planned 3–6 month refinement phase covering lysis optimization, dipstick tuning, and scalability, followed by a 4–8 month phase focused on bioinformatic target selection and assay signal optimization. The technology is at a technology readiness level appropriate for collaborative development toward field validation.